2,2'-azobis(2-amidinopropane) has been researched along with Impaired Glucose Tolerance in 1 studies
2,2'-azobis(2-amidinopropane): water-soluble free-radical initiator
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haffner, SM | 1 |
| Agil, A | 1 |
| Mykkanen, L | 1 |
| Stern, MP | 1 |
| Jialal, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diabetes and Cardiovascular Risk In Mexico City (San Antonio Heart Study)[NCT00005146] | 0 participants | Observational | 1979-05-31 | Completed | |||
| Incidence of Diabetes and Cardiovascular Disease in Mexican Americans[NCT00005205] | 0 participants | Observational | 1987-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for 2,2'-azobis(2-amidinopropane) and Impaired Glucose Tolerance
| Article | Year |
|---|---|
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |
Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
Topics: Amidines; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; | 1995 |